blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0524899

EP0524899 - Recombinant DNA molecules coding for the VB2 T cell receptor, method of preparation, antibodies and medicaments containing them [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  13.03.1998
Database last updated on 19.10.2024
Most recent event   Tooltip13.03.1998Application deemed to be withdrawnpublished on 29.04.1998 [1998/18]
Applicant(s)For all designated states
IMMUNOTECH S.A.
70, route Léon Lachamp Case 915- Luminy
F-13288 Marseille Cédex 9 / FR
[1993/04]
Inventor(s)01 / Romagne, François
21 avenue Mazargues
F-13008 Marseille / FR
02 / Van Agthoven André
15 avenue Joseph Crovetto
F-13009 Marseille / FR
03 / Malissen, Bernard
11 avenue de la Pinède
F-13009 Marseille / FR
04 / Besnardeau, Lydia
16 boulevard Michelet
F-13008 Marseille / FR
[1993/04]
Representative(s)Santarelli
Tour Trinity
1 bis Esplanade de la Défense
92035 Paris La Défense Cedex / FR
[N/P]
Former [1993/04]Rinuy, Santarelli
14, avenue de la Grande Armée
F-75017 Paris / FR
Application number, filing date92430015.530.04.1992
[1993/04]
Priority number, dateFR1991000571202.05.1991         Original published format: FR 9105712
[1993/04]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report 
No.:EP0524899
Date:27.01.1993
Language:FR
[1993/04]
Search report(s)(Supplementary) European search report - dispatched on:EP18.08.1992
ClassificationIPC:C12N15/12, C12N15/79, C12P21/08, A61K39/395, G01N33/577
[1993/04]
CPC:
A61P29/00 (EP); A61P3/06 (EP); A61P3/08 (EP);
A61P31/04 (EP); A61P37/00 (EP); C07K14/7051 (EP);
C07K16/2809 (EP); A61K38/00 (EP); C07K2319/00 (EP);
C07K2319/40 (EP) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1993/04]
TitleGerman:Rekombinante DNS-Moleküle kodierend für VB2-T-Zelle-Rezeptor, Verfahren zur Herstellung, Antikörper und Arzneimittel, die diese enthalten[1993/04]
English:Recombinant DNA molecules coding for the VB2 T cell receptor, method of preparation, antibodies and medicaments containing them[1993/04]
French:Nouvelles molécules d'ADN recombinants contenant la partie codante d'une chaîne VB2 du récepteur pour l'antigène des cellules T, procédé de préparation, anticorps et médicaments les renfermant[1993/04]
Examination procedure21.07.1993Examination requested  [1993/37]
17.01.1996Despatch of a communication from the examining division (Time limit: M04)
30.04.1996Reply to a communication from the examining division
20.01.1997Despatch of a communication from the examining division (Time limit: M09)
31.10.1997Application deemed to be withdrawn, date of legal effect  [1998/18]
28.11.1997Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [1998/18]
Fees paidRenewal fee
18.04.1994Renewal fee patent year 03
19.04.1995Renewal fee patent year 04
17.04.1996Renewal fee patent year 05
17.04.1997Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO8606413  (CALIFORNIA INST OF TECHN [US]);
 [Y]EP0340793  (YEDA RES & DEV [IL]);
 [A]EP0097518  (DANA FARBER CANCER INST INC [US])
 [YD]  - CELL vol. 37, 1984, CAMBRIDGE NA US pages 1101 - 1110; M.MALISSEN ET AL.: 'Mouse T cell antigen receptor:structure and organization...'
 [A]  - EMBASE DATABASE,Excerpta Medica Amsterdam,Abstract No.90391380 Bismuth G. et al.'A human TCR-IG chimeric protein used to generate a TCR-alpha chain...'
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.